Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
CURR | US
-0.28
-11.76%
Healthcare
Drug Manufacturers-Specialty & Generic
01/01/1970
21/10/2024
2.10
2.20
2.34
2.10
Avenir Wellness Solutions Inc. a wellness platform technology company which develops proprietary wellness nutraceutical and topical delivery systems. The company's pharmaceutical drug programs include CUREfilm Blue a sildenafil oral thin film (OTF) for the treatment of erectile dysfunction; CUREfilm Canna a cannabinoid product with optimized pharmacokinetic profiles using microCURE and CUREfilm technology; CUREfilm Anti-Viral an orally bio-available anti-viral of an existing therapeutic leveraging existing pre-clinical/clinical safety and toxicity data; and CUREfilm Central Nervous System a novel dosage form to treat mental health disorders such as depression PTSD addiction disorders obsessive compulsive disorders and anxiety. It also sells various wellness products under its distribution partners' brands. In addition the company develops 50000IU and Vitamin D3 OTF for oral administration. It has a licensing agreement with Canopy Growth Corporation. The company was formerly known as CURE Pharmaceutical Holding Corp. and changed its name to Avenir Wellness Solutions Inc. in January 2023. Avenir Wellness Solutions Inc. was founded in 2011 and is headquartered in Sherman Oaks California.
View LessPositive Momentum
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
134.0%1 month
131.4%3 months
131.4%6 months
131.4%-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
1.06
Range1M
1.06
Range3M
1.06
Rel. volume
0.71
Price X volume
20.37K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Procaps Group S.A. Warrants | PROCW | Drug Manufacturers-Specialty & Generic | 0.029 | 0 | 20.83% | n/a | 0.00% |
Biofrontera Inc. Warrants | BFRIW | Drug Manufacturers-Specialty & Generic | 0.0209 | 0 | 1.95% | n/a | 13.20% |
Sunshine Biopharma Inc. Warrant | SBFMW | Drug Manufacturers-Specialty & Generic | 0.105 | 0 | 0.77% | n/a | 2.46% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Blackstone/GSO Senior Floating Rate Term Fund | BSL | Textile Manufacturing | 14.21 | 0 | 0.00% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | - | 24.85 | - |
Ent. to Revenue | - | 361.91 | - |
PE Ratio | - | 30.05 | - |
Price to Book | - | 13.15 | - |
Dividend Yield | - | 2.94 | - |
Std. Deviation (3M) | 131.43 | 65.24 | Riskier |
Debt to Equity | - | -1.88 | - |
Debt to Assets | - | 0.48 | - |
Market Cap | - | 3.71B | - |